Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FE0QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,574
Award facts
- Contract value 100% obligated
- $12,574.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $12,574.22. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award through open competition. The order is scheduled for ultimate completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards reflects its capability to fulfill diverse federal medical procurement requirements, from specialty medications to brand-name and generic drugs, vaccines, and medical supplies. As a non-set-aside award, this delivery order reflects the company's competitive position within the broader pharmaceutical prime vendor marketplace and its ongoing role in supporting the Defense Health Agency and other federal healthcare customers through the DLA's global pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FE0QZ?
SPE2DB25FE0QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FE0QZ worth?
The government has obligated $12,574 on SPE2DB25FE0QZ.
Is contract SPE2DB25FE0QZ an order under another contract?
Yes. SPE2DB25FE0QZ is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE0QZ competed?
The extent of competition for SPE2DB25FE0QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award